Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus

References

• Maddox TM, Stanislawski MA, Grunwald GK, et al. Nonobstructive coronary artery disease and risk of myocardial infarction. Jama. 2014;312(17):1754–1763. doi:10.1001/jama.2014.1468125369489
   PubMed Web of Science ®Google Scholar
• Blanke P, Naoum C, Ahmadi A, et al. Long-term prognostic utility of coronary CT angiography in stable patients with diabetes mellitus. JACC Cardiovascular Imaging. 2016;9(11):1280–1288. doi:10.1016/j.jcmg.2015.12.02727568114
   PubMed Web of Science ®Google Scholar
• Saely CH, Aczel S, Marte T, Langer P, Drexel H. Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state. Diabetologia. 2004;47(1):145–146. doi:10.1007/s00125-003-1274-614676943
   PubMed Web of Science ®Google Scholar
• Olesen KKW, Madsen M, Egholm G, et al. Patients with diabetes without significant angiographic coronary artery disease have the same risk of myocardial infarction as patients without diabetes in a real-world population receiving appropriate prophylactic treatment. Diabetes Care. 2017;40(8):1103–1110. doi:10.2337/dc16-238828596210
   PubMed Web of Science ®Google Scholar
• Schmidt M, Maeng M, Madsen M, Sorensen HT, Jensen LO, Jakobsen CJ. The Western Denmark Heart Registry: its influence on cardiovascular patient care. Journal of the American College of Cardiology. 2018;71(11):1259–1272. doi:10.1016/j.jacc.2017.10.11029544611
   PubMed Web of Science ®Google Scholar
• Schmidt M, Maeng M, Jakobsen CJ, et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clinical Epidemiology. 2010;2:137–144.20865111
   PubMedGoogle Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clinical Epidemiology. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scandinavian Journal of Public Health. 2011;39(7 Suppl):30–33. doi:10.1177/140349481140148221775347
   PubMed Web of Science ®Google Scholar
• Johannesdottir SA, Horvath-Puho E, Ehrenstein V, Schmidt M, Pedersen L, Sorensen HT. Existing data sources for clinical epidemiology: the Danish National database of reimbursed prescriptions. Clinical Epidemiology. 2012;4:303–313. doi:10.2147/CLEP.S3758723204870
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.3558716
   PubMedGoogle Scholar
• Egholm G, Madsen M, Thim T, et al. Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention. Clin Epidemiol. 2016;8:415–423. doi:10.2147/CLEP.S10890627799822
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. European Journal of Epidemiology. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish register of causes of death. Scandinavian Journal of Public Health. 2011;39:26–29. doi:10.1177/1403494811399958
   PubMed Web of Science ®Google Scholar
• Zou G. A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology. 2004;159(7):702–706.15033648
   PubMed Web of Science ®Google Scholar
• Muhlestein JB, Lappe DL, Lima JA, et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. Jama. 2014;312(21):2234–2243. doi:10.1001/jama.2014.1582525402757
   PubMed Web of Science ®Google Scholar
• Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes. The New England Journal of Medicine. 2015;373(22):2117–2128. doi:10.1056/NEJMoa150472026378978
   PubMed Web of Science ®Google Scholar
• Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with Type 2 diabetes. The New England Journal of Medicine. 2016;375(19):1834–1844. doi:10.1056/NEJMoa160714127633186
   PubMed Web of Science ®Google Scholar
• Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in Type 2 diabetes. The New England Journal of Medicine. 2016;375(4):311–322. doi:10.1056/NEJMoa160382727295427
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Giugliano RP, Keech AC, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713–1722. doi:10.1056/NEJMoa161566428304224
   PubMed Web of Science ®Google Scholar
• Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa170791428845751
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Cardiovascular disease and risk management: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S86–S104. doi:10.2337/dc18-S00929222380
   PubMed Web of Science ®Google Scholar
• Kim JJ, Hwang BH, Choi IJ, et al. Impact of diabetes duration on the extent and severity of coronary atheroma burden and long-term clinical outcome in asymptomatic type 2 diabetic patients: evaluation by Coronary CT angiography. European Heart Journal Cardiovascular Imaging. 2015;16(10):1065–1073. doi:10.1093/ehjci/jev10626069244
   PubMed Web of Science ®Google Scholar
• Fox CS, Sullivan L, D’Agostino RB Sr., Wilson PW. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart study. Diabetes Care. 2004;27(3):704–708.14988289
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart (British Cardiac Society). 2004;90(12):1398–1403. doi:10.1136/hrt.2003.02610415547012
   PubMed Web of Science ®Google Scholar